Certain information marked as [***] has been excluded from this exhibit because it is both not material and is the type that the registrant treats as private or confidential CONSULTING AGREEMENTConsulting Agreement • November 10th, 2021 • Precision Biosciences Inc • Biological products, (no disgnostic substances) • North Carolina
Contract Type FiledNovember 10th, 2021 Company Industry JurisdictionThis CONSULTING AGREEMENT (“Agreement”) is made by and between Precision BioSciences, Inc., a Delaware corporation having a place of business at 302 East Pettigrew Street, Dibrell Building, Suite A-100, Durham, NC 27701 (“Company”), and Dr. David Thomson, an individual having an address at [***] as of July 2, 2021 (the “Effective Date”).
Certain information marked as [***] has been excluded from this exhibit because it is both not material and is the type that the registrant treats as private or confidential CONSULTING AGREEMENTConsulting Agreement • July 8th, 2021 • Precision Biosciences Inc • Biological products, (no disgnostic substances) • North Carolina
Contract Type FiledJuly 8th, 2021 Company Industry JurisdictionThis CONSULTING AGREEMENT (“Agreement”) is made by and between Precision BioSciences, Inc., a Delaware corporation having a place of business at 302 East Pettigrew Street, Dibrell Building, Suite A-100, Durham, NC 27701 (“Company”), and Dr. David Thomson, an individual having an address at [***] as of July 2, 2021 (the “Effective Date”).
Certain information marked as [***] has been excluded from this exhibit because it is both not material and is the type that the registrant treats as private or confidential CONSULTING AGREEMENTConsulting Agreement • May 13th, 2021 • Precision Biosciences Inc • Biological products, (no disgnostic substances) • North Carolina
Contract Type FiledMay 13th, 2021 Company Industry JurisdictionThis CONSULTING AGREEMENT (“Agreement”) is made by and between Precision BioSciences, Inc., a Delaware corporation having a place of business at 302 East Pettigrew Street, Dibrell Building, Suite A-100, Durham, NC 27701 (“Company”), and Dr. Chris Heery, an individual having an address at [***] as of April 23, 2021 (the “Effective Date”).